SECsense Logo

Editas Medicine, Inc. 8-K Filing: Key Insights & Updates

$EDIT
Form 8-K
Filed on: 2025-01-13
Source
Editas Medicine, Inc. 8-K Filing: Key Insights & Updates

Here are the key insights extracted from the provided section of the financial report:

  1. Entity Information:
  • Company Name: Editas Medicine, Inc.
  • CIK (Central Index Key): 0001650664
  • IRS Employer Identification Number (EIN): 46-4097528
  • Address: 11 Hurley Street, Cambridge, MA 02141
  • Contact Number: 617-401-9000
  1. Filing Information:
  • Filing Type: Form 8-K
  • Filing Date: January 13, 2025
  1. Security Information:
  • Common Stock: Par value of $0.0001 per share
  • Ticker Symbol: EDIT
  • Exchange: NASDAQ
  1. Period of Report:
  • Report Start Date: January 13, 2025
  • Report End Date: January 13, 2025

Summary:

This section details a Form 8-K filing by Editas Medicine, Inc., indicating an event or information that the company is required to disclose under SEC regulations. The filing date is January 13, 2025, and it pertains to the company's common stock listed on NASDAQ. The report presents crucial identification information about the company, including its address and contact details, which are relevant for investors and analysts.